Home/MindWalk Holdings/Dr. Lisa Monroe, M.D.
DL

Dr. Lisa Monroe, M.D.

Board Director

MindWalk Holdings

Roles

Board DirectoratMindWalk Holdings
Chief Medical OfficeratAdvance Pharmaceutical

MindWalk Holdings Pipeline

DrugIndicationPhase
MW-101Major Depressive Disorder (MDD)Phase 2
MW-201Alzheimer's Disease (Agitation)Phase 1/2
MW-301Parkinson's Disease PsychosisPhase 1
MW-401Generalized Anxiety Disorder (GAD)Pre-clinical
MW-501Cognitive Impairment associated with Schizophrenia (CIAS)Pre-clinical